Patrick Grossmann

Fam, let me put you on to Patrick Grossmann. This guy is the real deal in biotech startup land. He’s the CEO and co-founder of Invitris, a Munich-based company crushing it with protein-based drugs, especially bacteriophages, to fight off antibiotic-resistant infections. Think about that – super wild tech, tackling some of the nastiest health crises out there. No bullshit, he’s legit changing the game.

So, here’s the scoop: Patrick’s got a PhD plus an MBA – dude’s got brains and business chops. His background? Synthetic biology and entrepreneurship. Basically, he’s the perfect combo of scientist and startup guy. He jumped into this space after being part of the iGEM Munich Team back in 2018 – that’s where he and his co-founder Kilian Vogele started playing with cell-free protein expression tech. They spun Invitris out of that success, turning a college project into something that’s now backed by serious funding and big names.

Under Patrick’s leadership, Invitris built something called Phactory – it’s a proprietary platform that makes protein drugs at scale, super fast, and without needing all the traditional cell-based processes. It’s a big change for biotech manufacturing. That innovation caught a lot of eyes, earning them awards like the m4 Award, and grants like INCATE and the EIC Accelerator, which is basically the EU’s way of saying, “Hey, this is the future.”

He’s more than just a tech guy – Patrick’s been deep in the biz world too. He led Business Development at DEOXY before jumping into Invitris. The guy’s got hustle, turning ideas into real companies that make an impact.

And get this – he’s been part of Y Combinator’s W23 batch, one of the top startup accelerators out there. Invitris even launched on YC’s ‘Launch YC’ platform, which is like their way of saying, “This is the future trend.” All of this points to one thing: Patrick is relentless. He’s driven by a passion to solve real problems, and he’s not afraid to jump into the deep end with modern tech.

So, what does this all say about him? Patrick’s process is about turning science into startup magic. He’s the kind of guy who saw a huge problem – antibiotic resistance – and didn’t just complain. He built a team, created a platform, and got serious backing to make a dent. He’s motivated by making a difference, pushing boundaries, and proving that biotech can be scaled and commercialized without losing its soul.

Bottom line? Patrick Grossmann is a legit innovator, a biotech hustler who’s not just chasing the future trend but actually changing lives. That’s why he’s someone to watch – he’s the real deal, no cap.